Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

(2017) Fernando Magro et al.   Journal of Crohns & Colitis

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

(2017) Jean-Frederic Colombel et al.   LANCET

Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease

(2016) Daniël R. Hoekman et al.   EUROPEAN JOURNAL OF PEDIATRICS

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

Postoperative Medical Management of Crohn’s Disease: Prevention and Surveillance Strategies

(2016) Miguel Regueiro et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time

(2016) Karin Amcoff et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn’s disease: a long-term prospective study

(2016) Takayuki Yamamoto et al.   Therapeutic Advances in Gastroenterology

A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS

(2015) Stacy B Menees et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis

(2015) Takayuki Yamamoto et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery

(2015) Emily K. Wright et al.   GASTROENTEROLOGY

Faecal Calprotectin in Suspected Paediatric Inflammatory Bowel Disease

(2015) Pieter L.J. Degraeuwe et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Evaluation of Nine Consensus Indices in Delphi Foresight Research and Their Dependency on Delphi Survey Characteristics: A Simulation Study and Debate on Delphi Design and Interpretation

(2015) Stanislav Birko et al.   PLoS One

Low Fecal Calprotectin Predicts Sustained Clinical Remission in Inflammatory Bowel Disease Patients: A Plea for Deep Remission

(2014) Erik Mooiweer et al.   Journal of Crohns & Colitis

The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment

(2014) Klaus Theede et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease

(2013) G. D. Naismith et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: A prospective pilot study

(2013) Takayuki Yamamoto et al.   United European Gastroenterology Journal

Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method

(2012) Liselotte Coorevits et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

(2012) Pauliina Molander et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies

(2012) Ren Mao et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease

(2011) James D. Lewis   GASTROENTEROLOGY

Epidemiology and Natural History of Inflammatory Bowel Diseases

(2011) Jacques Cosnes et al.   GASTROENTEROLOGY

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

(2011) M. De Vos et al.   Journal of Crohns & Colitis

Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response

(2010) D. Turner et al.   GUT

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

(2009) Valle García-Sánchez et al.   Journal of Crohns & Colitis

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

(2009) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings

(2008) T. SIPPONEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES